Osteonecrosis of the Jaw
0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Oregon TherapeuticsFrance - Paris
1 programCONDOR Study of Osteonecrosis of the Jaws (TMJ)N/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
AmgenOsteonecrosis of the Jaw (ONJ) Case Registry
Oregon TherapeuticsCONDOR Study of Osteonecrosis of the Jaws (TMJ)
Clinical Trials (2)
Total enrollment: 636 patients across 2 trials
Osteonecrosis of the Jaw (ONJ) Case Registry
Start: Oct 2012Est. completion: Dec 2020327 patients
N/ACompleted
CONDOR Study of Osteonecrosis of the Jaws (TMJ)
Start: Jan 2007Est. completion: Sep 2008309 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.